SEC Form 4 · accession 0001209191-17-047889
PROTEOSTASIS THERAPEUTICS, INC. · PTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Franklin M Berger
Director
Period of report
Aug 3, 2017
Accepted (ET)
Aug 7, 2017 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001445283
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.20 | Aug 3, 2017 | A | 63,663 | A | — | Aug 3, 2027 | Common Stock | 63,663 | 63,663 | D |
Explanation of responses
- F1These securities shall vest and become exercisable in equal quarterly installments starting on August 3, 2017 until the option is fully vested and exercisable on August 3, 2018, subject to continued service.